Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

Organisation › Details

Calyxt Inc. (Nasdaq Global Market: CLXT)

http://www.calyxt.com

	Start	2015-05-01 renamed
	Group	Cellectis (Group)
	Predecessor	Cellectis Plant Sciences Inc.
	Industry	genomic technology
	Industry 2	transgenic plant
	Person	Blome, James A. (Jim) (Cellectis 201810– CEO of Calyxt Inc before Bayer CropScience LP + Valent + Agrliance)
	Person 2	Tripodi, Federico A. (Cellectis 201609c– CEO of Calyxt before Monsanto)

	Street	600 County Road D W. Suite 8
	City	55112 New Brighton, MN
	Tel	+1-651-683-2807
		Address record changed: 2015-05-12

Basic data	Employees	n. a.
	Currency	USD
	Annual sales	399,000 (revenue (2016) 2016-12-31)
	Profit	-12,086,000 (2016-12-31)
	Cash	3,007,000 (2017-03-31)


		Record changed: 2019-07-13

More documents for Cellectis (Group)

[1] Cellectis S.A.. (1/12/20). "Press Release: Iovance Biotherapeutics and Cellectis Enter into a Research Collaboration and Exclusive Worldwide License Agreement". San Carlos, CA & New York, NY....
[2] Cellectis S.A.. (10/29/19). "Press Release: First Patient Dosed with Off-the-Shelf UCARTCS1 Product Candidate for Relapsed/Refractory Multiple Myeloma". New York, NY....
[3] Cellectis S.A.. (10/1/19). "Press Release: Cellectis and Lonza Enter cGMP Manufacturing Service Agreement for Cellectis’ Allogeneic UCART Product Candidates". Basel & New York, NY....
[4] Allogene Therapeutics, Inc.. (12/3/18). "Press Release: Allogene Therapeutics Presents Data from Preclinical Study of ALLO-715 (anti-BCMA) Demonstrating Allogeneic CAR T Potential in Multiple Myeloma at the 2018 ASH Annual Meeting". South San Francisco,...
[5] Cellectis S.A.. (9/19/18). "Press Release: CAR-T Pioneer Dr. Stephan A. Grupp to Join Cellectis Clinical Advisory Board". New York, NY....
[6] Cellectis S.A.. (9/18/18). "Press Release: Calyxt Appoints CEO, Jim Blome, Former President & CEO of Bayer CropScience LP". Minneapolis, MN & New York, NY....
[7] Cellectis S.A.. (6/12/18). "Press Release: Cellectis Publishes Novel Methods to Improve the Clinical Use of Chimeric Antigen Receptor T-Cell Therapy in Scientific Reports". New York....
[8] Calyxt, Inc.. (5/22/18). "Press Release: Calyxt Announces Successful Closing of $60.9 Million Public Offering". Minneapolis, MN....
[9] Calyxt, Inc.. (5/15/18). "Press Release: Bayer CropScience, LP Agrees to Settle Lawsuit Filed by Calyxt in Delaware Chancery Court". Minneapolis, MN....
[10] Cellectis S.A.. (5/7/18). "Press Release: Cellectis Reports 1st Quarter 2018 Financial Results". New York, NY....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]